Home / Central Data Catalog / IMPACT_EVALUATION / TJK_2014_HRBFIE-FBL_V01_M
impact_evaluation

Health Results Based Financing Impact Evaluation 2014, Health Facility Baseline Survey

Tajikistan, 2014 - 2015
Get Microdata
Reference ID
TJK_2014_HRBFIE-FBL_v01_M
DOI
https://doi.org/10.48529/s143-rw94
Producer(s)
Damien de Walque, Aneesa Arur, Gil Shapira
Collection(s)
Impact Evaluation Surveys
Metadata
Documentation in PDF DDI/XML JSON
Created on
Mar 30, 2017
Last modified
Mar 30, 2017
Page views
257777
Downloads
14630

Data file: f23_cba_children

Criterion Based Audit: CBA2 - Children from 2 months up to years old

Cases: 793
Variables: 378

Variables

C2_38_3F
Child treated to prevent low blood sugar
C2_38_3G
Follow up in 2 days scheduled
C2_38_3H
Referred for further assessment
C2_39_1
Has the patient referred to hospital?
C2_39_2
Has the patient referred to Specialist?
C2_39_3
Has the pre-referral treatment initiated?
C2_39_3A
First dose of antibiotic given
C2_39_3B
Vitamin A
C2_39_3C
Tetracycline eye ointment applied
C2_39_3D
Mouth ulcers treated with gentian violet
C2_39_3E
Paracetamol given for high fever (38,5 C or above)
C2_39_3F
Child treated to prevent low blood sugar
C2_39_3G
Follow up in 2 days scheduled
C2_39_3H
Referred for further assessment
C2_40_1
Has the patient referred to hospital?
C2_40_2
Has the patient referred to Specialist?
C2_40_3
Has the pre-referral treatment initiated?
C2_40_3A
First dose of antibiotic given
C2_40_3B
Vitamin A
C2_40_3C
Tetracycline eye ointment applied
C2_40_3D
Mouth ulcers treated with gentian violet
C2_40_3E
Paracetamol given for high fever (38,50 C or above)
C2_40_3F
Child treated to prevent low blood sugar
C2_40_3G
Follow up in 2 days scheduled
C2_40_3H
Referred for further assessment
C2_41_1
Has the patient referred to hospital?
C2_41_2
Has the patient referred to Specialist?
C2_41_3
Has the pre-referral treatment initiated?
C2_41_3A
First dose of antibiotic given
C2_41_3B
Vitamin A
C2_41_3C
Tetracycline eye ointment applied
C2_41_3D
Mouth ulcers treated with gentian violet
C2_41_3E
Paracetamol given for high fever (38,50 C or above)
C2_41_3F
Child treated to prevent low blood sugar
C2_41_3G
Follow up in 2 days scheduled
C2_41_3H
Referred for further assessment
C2_42_1
Has the patient referred to hospital?
C2_42_2
Has the patient referred to Specialist?
C2_42_3
Has the pre-referral treatment initiated?
C2_42_3A
First dose of antibiotic given
C2_42_3B
Vitamin A
C2_42_3C
Tetracycline eye ointment applied
C2_42_3D
Mouth ulcers treated with gentian violet
C2_42_3E
Paracetamol given for high fever (38,50 C or above)
C2_42_3F
Child treated to prevent low blood sugar
C2_42_3G
Follow up in 2 days scheduled
C2_42_3H
Referred for further assessment
C2_43
Weight recorded
C2_44
Palmar Pallor observed and recorded
C2_45
Edema of both feet observed and recorded
C2_46
Wight for age determined and recorded
C2_47A
Severe malnutrition or severe anemia
C2_47B
Anemia or very low weight
C2_47C
No anemia and not very low weight
C2_47D
Other
C2_47D_OTHER
c2.47d_Other
C2_48
Severe malnutrition or severe anemia
C2_48_1
Has the patient referred to hospital?
C2_48_2
Has the patient referred to Specialist?
C2_48_3
Has the pre-referral treatment initiated?
C2_48_3A
Vitamin A
C2_48_3B
Iron
C2_48_3C
Follow up visit scheduled
C2_48_3D
Mother consulted on feeding
C2_49_1
Has the patient referred to hospital?
C2_49_2
Has the patient referred to Specialist?
C2_49_3
Has the pre-referral treatment initiated?
C2_49_3A
Vitamin A
C2_49_3B
Iron
C2_49_3C
Follow up visit scheduled
C2_49_3D
Mother consulted on feeding
C2_50_1
Has the patient referred to hospital?
C2_50_2
Has the patient referred to Specialist?
C2_50_3
Has the pre-referral treatment initiated?
C2_50_3A
Vitamin A
C2_50_3B
Iron
C2_50_3C
Follow up visit scheduled
C2_50_3D
Mother consulted on feeding
Total: 378
Back to Catalog

This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser. To learn more about cookies, click here.